Armilon 1 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Armilon 1 mg Tablet contains anastrozole, an aromatase inhibitor. Its labelling describes it for treating early breast cancer in women who have completed menopause, and as a first-line treatment for advanced breast cancer where the cancer has spread within the breasts or to other parts of the body. It is described as lowering the amount of estrogen, a natural female hormone that breast cancer cells need to grow, thereby slowing the growth of some breast cancer cells.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of early breast cancer in women who have completed menopause
- Described as a first-line treatment for advanced breast cancer that has spread within the breasts or to other parts of the body
- Described as lowering estrogen levels to slow the growth of some breast cancer cells
Described Dosage & Administration
- Taken after consulting a doctor
- The dosage and duration advised by the doctor should be strictly followed
- The dosage depends on the patient’s condition
Described Side Effects
Commonly described side effects include:
- Osteoporosis
- Skin rash
- Weakness
- Nausea
- Hot flashes
Most of these are described as short-lived and as disappearing after some time; a doctor should be consulted if they last longer.
Precautions
- Described as possibly unsafe for pregnant mothers — a doctor should be consulted before use
- Described as unsafe for breastfeeding mothers, as it may cause toxicity to the baby
- Patients with kidney or liver problems are advised to use it with caution
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains anastrozole and is used for early and advanced breast cancer in postmenopausal women. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as lowering the amount of estrogen, which breast cancer cells need to grow, thereby slowing the growth of some breast cancer cells.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.